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ABSTRACT 
Carvedilol a poorly water soluble drug undergoes extensive first pass metabolism, which reduces its bioavailability to 25-30%. Fast dissolving 
tablets of Carvedilol were prepared with the purpose of delivering the drug directly into the systemic circulation and bypassing the hepatic first 
pass metabolism with a concomitant increase in bioavailability. The solubility of Carvedilol was improved by forming inclusio n complex with 
cyclodextrin which was then further used for the formulation of Fast dissolving tablet.  
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1. INTRODUCTION 
Carvedilol is indicated for the treatment of mild to severe 
chronic heart failure, Left ventricular dysfunction following 
myocardial infraction in clinically stable patients and 
hypertension. Carvedilol is a poorly water-soluble oral 
antihypertensive agent, with problems of variable 
bioavailability and bio-equivalence related to its poor water-
solubility. In present work attempt will be made to design 
and evaluation of Fast dissolving tablets of Carvedilol for the 
effective management of angina pectoris, hypertension etc. 1 
In view of substantial first pass effect and its shorter plasma 
half life therefore is an ideal drug candidate for Fast 
dissolving drug delivery system. 2 To formulate the fast 
dissolving dosage form of Carvedilol to Improve patient 
compliance, Ease of administration, Increase bioavailability 
of drug and avoid first pass effect.3 
Fast Dissolving Tablet is solid unit dosage form which 
disintegrates or dissolves rapidly in the mouth without 
chewing and water. To design fast dissolving oral tablet of 
Carvedilol in order to improve bioavailability, ease of 
administration and patient compliance. In the present study, 
fast dissolving tablet of Carvedilol was attempted with the 
aim to develop a dosage form that was easy to administer, 
provided fast release of drug and also enhanced 
bioavailability of the drug. Pregastric absorption through 
mouth, pharynx and oesophagus, could enhance the 
bioavailability by suitable formulation approaches and also 
provide local action, as the drug releases in saliva and passes 
down in to the stomach. The market survey revealed that the 
conventional tablets are available. Hence it was thought to 
formulate novel and convenient solid dosage form i.e. fast 
dissolving tablet. Carvedilol was selected as a drug candidate 
for the formulation of fast dissolving tablet for the following 
reasons, It is practically insoluble in water therefore taste 
related problems can be avoided. It is chemically stable. 
Having t1/2 of – 7 to 10 hrs. In view of substantial first pas 
effect and its shorter plasma half life, therefore is an ideal 
drug candidate for fast dissolving tablet. Appropriate 
disintegrating agents and highly hydrophilic excipients are 
the main ingredients of fast dissolving tablets. 
2. IDEAL CHARACTERISTICS Of FDT 4,5 
It should require no water for administration  
It should dissolve/disperse in mouth within few seconds  
It should have pleasant mouth feel  
Ability to permeate to mucosal layer  
Compatibility of drug with taste masking agent  
It should leave minimum or no residue after oral 
administration  
Manufacturing should involve easy conventional techniques. 
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3. ADVANTAGES OF FDT 6-9  
FDT can be easily administered to pediatric and geriatric 
patients  
Safest route of administration  
Rapid onset of action  
Enhancement in bioavailability  
High drug loading can be achieved  
Economic drug delivery system 
4. DISADVANTAGES OF FDT 6,7  
FDTs usually possesses insufficient mechanical strength  
In some cases taste masking agents make FDTs as expensive  
5. DRUGS SUITABLE FOR FDT 8, 9  
Drugs which are having less dose  
Stable in water and saliva  
Bitter drugs are not suitable for FDT. But by using taste 
masking agent’s bitter drugs can be formulated as F. 
6. TECHNOLOGIES USED FOR MANUFACTURING OF 
MDTS 
In the recent past, several new advanced technologies have 
been introduced for the manufacturing of FDTs with ideal 
properties like less disintegration time, pleasant mouth feel, 
exceptional taste masking and sugar free tablets for diabetic 
patients. The technologies used for manufacturing of FDTs 
broadly classified in two category one is patented another 
one is nonpatented technologies.  
6.1 Lyophilization or Freeze-drying:  
Formation of porous product in freeze-drying process is 
exploited in formulating FDTs. Lyophilization is a process, 
which includes the removal of solvent from a frozen 
suspension or solution of drug with structure-forming 
additives.8 Freeze-drying of drug along with additives 
imparts glossy amorphous structure resulting in highly 
porous and lightweight product. The resulting tablet has 
Rapid disintegration and dissolution when placed on the 
tongue and the freeze-dried unit dissolves instantly to 
release the drug. However, the FDTs formed by 
lyophilization have low mechanical strength, poor stability at 
higher temperature, and humidity 8  
6.2 Molding:  
In this method, molded tablets are prepared by using water-
soluble ingredients so that the tablets dissolve completely 
and rapidly. The powder blend is moistened with a 
hydroalcoholic solvent and is molded into tablets under 
pressure lower than that used in conventional tablet 
compression. The solvent is then removed by air-drying 
.Molded tablets are very less compact than compressed 
tablets. These posses porous structure that increase 
dissolution9  
6.3 Cotton candy process:  
This process is so named as it utilizes a unique spinning 
mechanism to produce floss-like crystalline structure, which 
mimic cotton candy. Cotton candy process10 involves 
formation of matrix of polysaccharides or saccharides by 
simultaneous action of flash melting and spinning. The 
matrix formed is partially re-crystallized to have improved 
flow properties and compressibility. This candy floss matrix 
is then milled and blended with active ingredients and 
excipients and subsequently compressed to FDTs.  
6.4 Spray drying:  
This technology produces highly porous and fine powders as 
the processing solvent is evaporated during the process11. In 
this method to prepare FDTs hydrolyzed and nonhydrolyzed 
gelatin were used as supporting matrix, mannitol as bulking 
agent and sodium starch glycolate or crosscarmellose 
sodium as superdisintegrant. Disintegration and dissolution 
were further increased by adding acidic substances like citric 
acid or alkali substance like sodium bicarbonate. This 
formulation technique gives porous powder and 
disintegration time < 20 sec 12, 13.  
6.5 Mass extrusion: This technology involves softening the 
active blend using the solvent mixture of water-soluble 
polyethylene glycol and methanol and subsequent expulsion 
of softened mass through the extruder or syringe to get a 
cylinder of the product into even segments using heated 
blade to form tablets14  
6.6 Melt granulation:  
In this process, FDTs can be prepared by incorporating a 
hydrophilic waxy binder (super polystate) PEG-6-stearate. 
Super polystate is a waxy material with an m. pt. of 33- 37°C 
and a hydrophilic- lipophilic balance of9. It not only acts as a 
binder and increases the physical resistance of tablets, but 
also helps in the disintegration of tablets as it melts in the 
mouth and solubilizes rapidly leaving no residue. Super 
polystate was incorporated in the formulation of FDTs by 
melt granulation method where granules are formed by the 
molten form of this material 15  
6.7 Phase transition process:  
Kuno et. al.,16 investigated processes for the disintegration of 
FDTs by phase transition of sugar alcohols using erythritol 
(m. pt. 122°C), xylitol (m. pt. 93-95°C), trehalose (97°C), and 
mannitol (166°C). Tablets were produced by compressing a 
powder containing two sugar alcohols with high and low 
melting points and subsequent heating at a temperature 
between their melting points. Before heating process, the 
tablets do not have sufficient hardness because of low 
compatibility. The tablet hardness was increased after 
heating process, due to the increase of inter particle bonds or 
the bonding surface area in tablets induced by phase 
transition of lower melting point sugar alcohol.  
6.8 Sublimation: The presence of a highly porous structure 
in the tablet matrix is the key factor for rapid disintegration 
of FDTs. Even though the conventional tablets contain highly 
water-soluble ingredients, they often fail to disintegrate 
rapidly because of low porosity. To improve the porosity, 
volatile substances such as camphor can be used in tableting 
process, which sublimated from the formed tablet17. 
Developed FDTs utilizing camphor, a subliming material that 
is removed from compressed tablets prepared using a 
mixture of mannitol and camphor. Camphor was sublimated 
in vacuum at 80°C for 30 min after preparation of tablets.  
6.9 Direct compression methods:  
This technique is easy way to formulate FDTs since limited 
number of processing steps, low manufacturing cost and also 
accommodate high dose the final weight of tablet can easily 
exceed that of other production method18.  
The disintegration and dissolution of directly compressed 
tablets depends on single or combined effect of disintegrant, 
water soluble excipients and effervescing agents. 
Disintegrant efficacy is strongly affected by tablet size and 
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hardness. Disintegration properties can be optimized by 
medium or low tablet size, low hardness and low physical 
resistance .It is essential to choose a suitable and an 
optimum concentration of disintegrant to ensure fast 
disintegration and high dissolution rates18,19. The addition of 
water soluble excipients or effervescent agent can further 
increase dissolution or disintegration properties. Super 
disintegrants provide fast disintegration due to combine 
effect of swelling and water absorption. As an effect of 
swelling of super disintegrant the wetted surface of the 
carrier increase, which promotes wettability and 
dispersibility of the system and thereby increase the 
disintegration and dissolution 20, 21, 22.  
The optimum concentration of superdisintegrant can be 
selected according to critical concentration of disintegrant. 
Below this concentration the tablet disintegration time is 
inversely proportional to the concentration of 
superdisintegrant, where as if concentration of 
superdisintegrants incorporated in tablet is above the critical 
concentration, the disintegration time remains 
approximately constant or even increases. 
7. PATENTED TECHNOLOGIES FOR FAST 
DISSOLVING TABLETS 
7.1 Zydis Technology:  
Zydis formulation is a unique freeze dried tablet in which 
drug is physically entrapped or dissolved within the matrix 
of fast dissolving carrier material. When zydis units are put 
into the mouth, the freeze-dried structure disintegrates 
instantaneously and does not require water to aid 
swallowing. The zydis matrix is composed of many material 
designed to achieve a number of objectives. To impart 
strength and resilience during handling, polymers such as 
gelatin, dextran or alginates are incorporated. These form a 
glossy amorphous structure, which imparts strength. To 
obtain crystallinity, elegance and hardness, saccharides such 
as mannitol or sorbitol are incorporated. Water is used in the 
manufacturing process to ensure production of porous units 
to achieve rapid disintegration while various gums are used 
to prevent sedimentation of dispersed drug particles in the 
manufacturing process. Collapse protectants such as glycine 
prevent the shrinkage of zydis units during freeze-drying 
process or long-term storage.23 Zydis products are packed in 
blister packs to protect the formulation from moisture in the 
environment.  
7.2 Durasolv Technology:  
Durasolv is the patented technology of CIMA labs. The tablets 
made by this technology consist of drug, filler and a 
lubricant. Tablets are prepared by using conventional 
tabletting equipment and have good rigidity. These can be 
packaged into conventional packaging system like blisters.24 
Durasolv is an appropriate technology for product requiring 
low amounts of active ingredients.  
7.3 Orasolv Technology:  
CIMA labs have developed Orasolv Technology. In this 
system active medicament is taste masked. It also contains 
effervescent disintegrating agent. Tablets are made by direct 
compression technique at low compression force in order to 
minimize oral dissolution time. Conventional blenders and 
tablet machine is used to produce the tablets. The tablets 
produced are soft and friable.24  
7.4 Flash Dose Technology:  
Flash dose technology has been patented by fuisz. Nurofen 
meltlet, a new form of ibuprofen as melt in mouth tablets 
prepared using flash dose technology is the first commercial 
product launched by Biovail Corporation. Flash dose tablets 
consist of self binding shear form matrix termed as “floss”. 
Shear form matrices are prepared by flash heat processing.24 
7.5 Wow tab Technology: 
Wow tab technology is patented by Yamanouchi 
Pharmaceutical CoWOW means “Without Water”. In this 
process, combination of low mouldability saccharides and 
high mouldability saccharides is used to obtain a rapidly 
melting strong tablet. The active ingredient is mixed with a 
low mouldability saccharide (e.g. lactose, glucose, and 
mannitol) and granulated with a high mouldability 
saccharide (e.g. Maltose, oligosaccharides).24 
8. EVALUATION OF MOUTH DISSOLVING TABLET 
FDTs formulations have to be evaluated for the following 
evaluation test 25,26.  
8.1 Size and Shape:  
The size and shape of the tablet can be dimensionally 
described, monitored and controlled. Tablet thickness: 
Tablet thickness is an important characteristic in 
reproducing appearance and also in counting by using filling 
equipment. Some filling equipment utilizes the uniform 
thickness of the tablets as a counting mechanism. Ten tablets 
were taken and their thickness was recorded using 
micrometer.  
8.2 Uniformity of weight:  
I.P. procedure for uniformity of weight was followed, twenty 
tablets were taken and their weight was determined 
individually and collectively on a digital weighing balance. 
The average weight of one tablet was determined from the 
collective weight. The weight variation test would be a 
satisfactory method of determining the drug content 
uniformity. Average weight of Tablets (mg) Maximum 
percentage difference allowed 130 or less 10 130-324 7.5 
More than 324 5.  
8.3 Tablet hardness:  
Hardness of tablet is defined as the force applied across the 
diameter of the tablet in the order to break the tablet. The 
resistance of the tablet to chipping, abrasion or breakage 
under condition of storage transformation and handling 
before usage depends on its hardness. Hardness of the tablet 
of each formulation was determined using Monsanto 
Hardness tester.  
8.4 Friability:  
It is measured of mechanical strength of tablets. Roche 
friabilator was used to determine the friability by following 
procedure. A pre weighed tablet was placed in the friabilator. 
Friabilator consist of a plastic-chamber that revolves at 25 
rpm, dropping those tablets at a distance of 6 inches with 
each revolution. The tablets were rotated in the friabilator 
for at least 4 minutes. At the end of test tablets were dusted 
and reweighed, the loss in the weight of tablet is the measure 
of friability and is expressed in percentage as; In-Vivo. 
8.5 Disintegration test:  
The test was carried out on 6 tablets using the apparatus 
specified in I.P.-1996 distilled water at 37°C ± 2°C was used 
as a disintegration media and the time in second is taken for 
complete disintegration of the tablet with no palatable mass 
remaining in the apparatus was measured in seconds. 
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8.6 Wetting time:  
The method reported by Yunixia et al., was followed to 
measure tablet wetting time. A piece of tissue paper (12 cm X 
10.75 cm) folded twice was placed in a small petridish (ID = 
6.5 cm) containing 6 ml of Sorenson’s buffer pH 6.8. A tablet 
was put on the paper, and the time for complete wetting was 
measured. Three trials for each batch and the standard 
deviation were also determined. In vitro dispersion time: In 
vitro dispersion time was measured by dropping a tablet in a 
beaker containing 50 ml of Sorenson’s buffer pH 6.8. Three 
tablets from each formulation were randomly selected and in 
vitro dispersion time was performed. 
9. CONCLUSION 
The FDTs have potential advantages over conventional 
dosage forms, with their improved patient compliance, 
convenience, bioavailability and rapid onset of action had 
drawn the attention of many manufactures over a decade. 
FDTs formulations obtained by some of these technologies 
have sufficient mechanical strength, quick 
disintegration/dissolution in the mouth without water. 
These FDTs can be used easily in children who have lost their 
primary teeth and in geriatric patients who have lost their 
teeth permanently. They remain solid during storage, which 
aid in stability of dosage forms and transform into liquid 
form within few seconds after its administration. As they 
have significant advantages as both solid and liquid dosage 
forms, FDTs may be developed for most of the available 
drugs in near future. 
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